USANA Health Sciences (USNA) Stock Forecast, Price Target & Predictions
USNA Stock Forecast
USANA Health Sciences stock forecast is as follows: an average price target of $38.00 (represents a -4.57% downside from USNA’s last price of $39.82) and
USNA Price Target
USANA Health Sciences Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | Linda Bolton Weiser | D.A. Davidson | $38.00 | $42.97 | -11.57% | -4.57% |
| May 07, 2024 | Linda Bolton Weiser | D.A. Davidson | $46.00 | $44.79 | 2.70% | 15.52% |
| Apr 27, 2022 | - | D.A. Davidson | $76.00 | $75.52 | 0.64% | 90.86% |
The latest USANA Health Sciences stock forecast, released on Jul 25, 2024 by Linda Bolton Weiser from D.A. Davidson, set a price target of $38.00, which represents a -11.57% decrease from the stock price at the time of the forecast ($42.97), and a -4.57% decrease from USNA last price ($39.82).
USANA Health Sciences Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 2 |
| Avg Price Target | - | $38.00 | $42.00 |
| Last Closing Price | $39.82 | $39.82 | $39.82 |
| Upside/Downside | -100.00% | -4.57% | 5.47% |
In the current month, the average price target of USANA Health Sciences stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to USANA Health Sciences's last price of $39.82. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
USANA Health Sciences Financial Forecast
USANA Health Sciences Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $221.08M | $213.37M | $238.20M | $248.36M | $227.96M | $233.30M | $264.47M | $272.87M | $310.52M | $274.35M | $336.84M | $307.98M | - | $298.51M | $258.99M | $266.62M | $271.30M | $260.60M |
| Avg Forecast | $296.69M | $294.53M | $283.69M | $267.82M | $222.51M | $211.30M | $216.28M | $228.59M | $215.48M | $206.14M | $215.75M | $226.84M | $212.42M | $212.80M | $231.14M | $240.22M | $203.80M | $244.20M | $265.00M | $267.32M | $271.93M | $268.07M | $332.62M | $301.47M | $291.47M | $278.80M | $256.33M | $240.68M | $252.75M | $254.85M |
| High Forecast | $301.06M | $298.87M | $287.88M | $271.77M | $225.79M | $214.42M | $219.47M | $231.96M | $218.66M | $209.18M | $218.93M | $230.18M | $215.55M | $220.68M | $234.54M | $243.77M | $206.81M | $247.80M | $265.00M | $270.42M | $275.09M | $271.17M | $336.47M | $304.97M | $294.85M | $282.03M | $259.30M | $243.47M | $255.68M | $257.80M |
| Low Forecast | $292.31M | $290.18M | $279.51M | $263.87M | $219.23M | $208.19M | $213.09M | $225.22M | $212.30M | $203.10M | $212.57M | $223.49M | $209.29M | $204.91M | $227.73M | $236.68M | $200.79M | $240.60M | $265.00M | $264.21M | $268.78M | $264.96M | $328.76M | $297.98M | $288.09M | $275.57M | $253.36M | $237.89M | $249.82M | $251.89M |
| # Analysts | - | - | - | - | - | - | - | - | - | 1 | - | - | 1 | 2 | 1 | 1 | - | - | - | - | 1 | 1 | 1 | 10 | 10 | 10 | 10 | 10 | 9 | 9 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.04% | 1.00% | 1.03% | 1.03% | 1.12% | 0.96% | 1.00% | 1.02% | 1.14% | 1.02% | 1.01% | 1.02% | - | 1.07% | 1.01% | 1.11% | 1.07% | 1.02% |
USANA Health Sciences's average Quarter revenue forecast for Mar 24 based on 0 analysts is $226.84M, with a low forecast of $223.49M, and a high forecast of $230.18M. USNA's average Quarter revenue forecast represents a 2.60% increase compared to the company's last Quarter revenue of $221.08M (Dec 23).
USANA Health Sciences EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - | - | - | 1 | - | - | 1 | 2 | 1 | 1 | - | - | - | - | 1 | 1 | 1 | 10 | 10 | 10 | 10 | 10 | 9 | 9 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $24.22M | $17.61M | $24.40M | $26.84M | $22.55M | $22.63M | $29.37M | $33.07M | $58.94M | $45.85M | $59.88M | $49.83M | - | $51.24M | $45.85M | $44.93M | $51.55M | $41.56M |
| Avg Forecast | $39.62M | $39.33M | $37.89M | $35.77M | $29.72M | $28.22M | $28.88M | $30.53M | $28.78M | $27.53M | $28.81M | $40.53M | $28.37M | $28.42M | $30.87M | $36.84M | $27.22M | $48.32M | $35.39M | $33.50M | $45.08M | $35.80M | $56.86M | $40.26M | $40.80M | $43.92M | $35.66M | $26.48M | $32.65M | $30.45M |
| High Forecast | $40.21M | $39.91M | $38.45M | $36.29M | $30.15M | $28.64M | $29.31M | $30.98M | $29.20M | $27.94M | $29.24M | $48.63M | $28.79M | $29.47M | $31.32M | $44.21M | $27.62M | $57.98M | $35.39M | $40.19M | $54.09M | $36.22M | $68.23M | $40.73M | $48.97M | $52.71M | $42.79M | $31.77M | $39.18M | $36.54M |
| Low Forecast | $39.04M | $38.75M | $37.33M | $35.24M | $29.28M | $27.80M | $28.46M | $30.08M | $28.35M | $27.12M | $28.39M | $32.42M | $27.95M | $27.37M | $30.41M | $29.48M | $26.82M | $38.65M | $35.39M | $26.80M | $36.06M | $35.39M | $45.48M | $39.79M | $32.64M | $35.14M | $28.53M | $21.18M | $26.12M | $24.36M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.85% | 0.62% | 0.79% | 0.73% | 0.83% | 0.47% | 0.83% | 0.99% | 1.31% | 1.28% | 1.05% | 1.24% | - | 1.17% | 1.29% | 1.70% | 1.58% | 1.37% |
0 analysts predict USNA's average Quarter EBITDA for Mar 24 to be $40.53M, with a high of $48.63M and a low of $32.42M. This is 67.34% upper than USANA Health Sciences's previous annual EBITDA (Dec 23) of $24.22M.
USANA Health Sciences Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - | - | - | 1 | - | - | 1 | 2 | 1 | 1 | - | - | - | - | 1 | 1 | 1 | 10 | 10 | 10 | 10 | 10 | 9 | 9 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $16.77M | $11.35M | $17.29M | $18.38M | $12.79M | $14.93M | $19.16M | $22.47M | $39.63M | $27.33M | $38.23M | $30.62M | - | $30.51M | $27.98M | $26.55M | $30.75M | $24.22M |
| Avg Forecast | $28.16M | $28.95M | $26.41M | $21.77M | $14.27M | $11.40M | $11.97M | $14.27M | $11.69M | $9.29M | $11.16M | $23.95M | $9.87M | $11.36M | $13.32M | $21.77M | $6.71M | $28.76M | $20.27M | $19.79M | $24.54M | $25.03M | $36.30M | $28.59M | $27.44M | $26.15M | $21.76M | $15.65M | $19.48M | $17.74M |
| High Forecast | $28.70M | $29.51M | $26.92M | $22.18M | $14.55M | $11.62M | $12.20M | $14.55M | $11.91M | $9.67M | $11.37M | $28.74M | $10.06M | $11.89M | $13.58M | $26.13M | $6.83M | $34.52M | $20.27M | $23.75M | $29.45M | $25.41M | $43.56M | $29.02M | $32.92M | $31.38M | $26.11M | $18.78M | $23.37M | $21.29M |
| Low Forecast | $27.62M | $28.40M | $25.90M | $21.35M | $14.00M | $11.18M | $11.74M | $14.00M | $11.46M | $8.72M | $10.94M | $19.16M | $9.49M | $10.65M | $13.07M | $17.42M | $6.58M | $23.01M | $20.27M | $15.83M | $19.63M | $24.65M | $29.04M | $28.16M | $21.95M | $20.92M | $17.41M | $12.52M | $15.58M | $14.20M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.70% | 1.00% | 1.30% | 0.84% | 1.91% | 0.52% | 0.95% | 1.14% | 1.61% | 1.09% | 1.05% | 1.07% | - | 1.17% | 1.29% | 1.70% | 1.58% | 1.37% |
USANA Health Sciences's average Quarter net income forecast for Mar 24 is $23.95M, with a range of $19.16M to $28.74M. USNA's average Quarter net income forecast represents a 42.85% increase compared to the company's last Quarter net income of $16.77M (Dec 23).
USANA Health Sciences SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - | - | - | 1 | - | - | 1 | 2 | 1 | 1 | - | - | - | - | 1 | 1 | 1 | 10 | 10 | 10 | 10 | 10 | 9 | 9 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $154.54M | $153.23M | $170.48M | $173.00M | $158.98M | $164.11M | $185.59M | $188.42M | $198.96M | $182.87M | $226.10M | $206.13M | - | $196.80M | $171.73M | $181.55M | $179.44M | $177.32M |
| Avg Forecast | $201.60M | $200.13M | $192.77M | $181.98M | $151.19M | $143.58M | $146.96M | $155.33M | $146.42M | $140.07M | $146.60M | $163.75M | $144.34M | $144.60M | $157.06M | $148.87M | $138.48M | $185.55M | $180.07M | $135.33M | $221.34M | $182.15M | $214.67M | $204.85M | $137.74M | $168.69M | $133.57M | $106.98M | $113.64M | $129.90M |
| High Forecast | $204.57M | $203.08M | $195.61M | $184.67M | $153.42M | $145.70M | $149.13M | $157.62M | $148.58M | $142.14M | $148.76M | $196.51M | $146.47M | $149.95M | $159.37M | $178.64M | $140.52M | $222.67M | $180.07M | $162.40M | $265.61M | $184.26M | $257.60M | $207.23M | $165.29M | $202.42M | $160.28M | $128.38M | $136.37M | $155.88M |
| Low Forecast | $198.62M | $197.18M | $189.92M | $179.30M | $148.97M | $141.46M | $144.80M | $153.04M | $144.26M | $138.01M | $144.44M | $131.00M | $142.21M | $139.24M | $154.74M | $119.09M | $136.44M | $148.44M | $180.07M | $108.27M | $177.07M | $180.04M | $171.74M | $202.47M | $110.19M | $134.95M | $106.85M | $85.59M | $90.92M | $103.92M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.07% | 1.06% | 1.09% | 1.16% | 1.15% | 0.88% | 1.03% | 1.39% | 0.90% | 1.00% | 1.05% | 1.01% | - | 1.17% | 1.29% | 1.70% | 1.58% | 1.37% |
USANA Health Sciences's average Quarter SG&A projection for Mar 24 is $163.75M, based on 0 Wall Street analysts, with a range of $131.00M to $196.51M. The forecast indicates a 5.96% rise compared to USNA last annual SG&A of $154.54M (Dec 23).
USANA Health Sciences EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - | - | - | 1 | - | - | 1 | 2 | 1 | 1 | - | - | - | - | 1 | 1 | 1 | 10 | 10 | 10 | 10 | 10 | 9 | 9 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $0.87 | $0.59 | $0.90 | $0.95 | $0.67 | $0.78 | $1.00 | $1.16 | $1.88 | $1.37 | $1.89 | $1.48 | - | $1.45 | $1.33 | $1.26 | $1.42 | $1.12 |
| Avg Forecast | $1.47 | $1.51 | $1.38 | $1.14 | $0.74 | $0.59 | $0.63 | $0.74 | $0.61 | $0.48 | $0.58 | $0.69 | $0.52 | $0.59 | $0.70 | $0.77 | $0.35 | $0.89 | $1.05 | $1.14 | $1.28 | $1.30 | $1.72 | $1.49 | $1.43 | $1.26 | $1.08 | $0.83 | $0.98 | $0.86 |
| High Forecast | $1.50 | $1.54 | $1.40 | $1.16 | $0.76 | $0.61 | $0.64 | $0.76 | $0.62 | $0.50 | $0.59 | $0.70 | $0.52 | $0.62 | $0.71 | $0.78 | $0.36 | $0.91 | $1.05 | $1.16 | $1.30 | $1.32 | $1.74 | $1.51 | $1.45 | $1.28 | $1.10 | $0.85 | $1.00 | $0.88 |
| Low Forecast | $1.44 | $1.48 | $1.35 | $1.11 | $0.73 | $0.58 | $0.61 | $0.73 | $0.60 | $0.46 | $0.57 | $0.68 | $0.50 | $0.56 | $0.68 | $0.75 | $0.34 | $0.87 | $1.05 | $1.12 | $1.26 | $1.28 | $1.69 | $1.46 | $1.41 | $1.25 | $1.06 | $0.82 | $0.97 | $0.85 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.69% | 1.00% | 1.29% | 1.24% | 1.91% | 0.88% | 0.95% | 1.02% | 1.47% | 1.05% | 1.10% | 1.00% | - | 1.15% | 1.23% | 1.51% | 1.44% | 1.30% |
According to 0 Wall Street analysts, USANA Health Sciences's projected average Quarter EPS for Mar 24 is $0.69, with a low estimate of $0.68 and a high estimate of $0.70. This represents a -20.69% decrease compared to USNA previous annual EPS of $0.87 (Dec 23).
USANA Health Sciences Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| LANC | Lancaster Colony | $179.29 | $216.00 | 20.48% | Buy |
| SMPL | Simply Good Foods Company | $33.60 | $40.22 | 19.70% | Buy |
| POST | Post | $115.15 | $135.00 | 17.24% | Buy |
| THS | TreeHouse Foods | $42.87 | $42.00 | -2.03% | Hold |
| USNA | USANA Health Sciences | $39.82 | $38.00 | -4.57% | - |
| BRBR | BellRing Brands | $59.36 | $41.27 | -30.48% | Buy |
USNA Forecast FAQ
Will USANA Health Sciences stock go up soon?
According to Wall Street analysts' prediction for USNA stock, the company can go down by -4.57% (from the last price of $39.82 to the average price target of $38), down by -4.57% based on the highest stock price target, and down by -4.57% based on the lowest stock price target.
Can USANA Health Sciences stock reach $60?
USNA's average twelve months analyst stock price target of $38 does not support the claim that USANA Health Sciences can reach $60 in the near future.
What are USANA Health Sciences's analysts' financial forecasts?
USANA Health Sciences's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $878.69M (high $891.65M, low $865.73M), average EBITDA is $117.35M (high $119.08M, low $115.62M), average net income is $51.92M (high $52.92M, low $50.93M), average SG&A $597.06M (high $605.87M, low $588.26M), and average EPS is $2.71 (high $2.76, low $2.66). USNA's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $1.14B (high $1.16B, low $1.13B), average EBITDA is $152.61M (high $154.86M, low $150.36M), average net income is $105.29M (high $107.31M, low $103.27M), average SG&A $776.47M (high $787.93M, low $765.02M), and average EPS is $5.5 (high $5.6, low $5.39).
Did the USNA's actual financial results beat the analysts' financial forecasts?
Based on USANA Health Sciences's last annual report (Dec 2023), the company's revenue was $921.01M, beating the average analysts forecast of $896.58M by 2.72%. Apple's EBITDA was $93.07M, missing the average prediction of $124.5M by -25.25%. The company's net income was $63.79M, beating the average estimation of $56.32M by 13.26%. Apple's SG&A was $651.25M, beating the average forecast of $594.86M by 9.48%. Lastly, the company's EPS was $3.3, beating the average prediction of $2.57 by 28.44%. In terms of the last quarterly report (Dec 2023), USANA Health Sciences's revenue was $221.08M, beating the average analysts' forecast of $212.42M by 4.08%. The company's EBITDA was $24.22M, missing the average prediction of $28.37M by -14.63%. USANA Health Sciences's net income was $16.77M, beating the average estimation of $9.87M by 69.92%. The company's SG&A was $154.54M, beating the average forecast of $144.34M by 7.07%. Lastly, the company's EPS was $0.87, beating the average prediction of $0.515 by 68.93%